A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants

Trial Identifier: 16008
Sponsor: AstraZeneca
Collaborator:
Eli Lilly and Company
NCTID:: NCT02540668
Start Date: September 2015
Primary Completion Date: January 2016
Study Completion Date: January 2016
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United States, IN Evansville, IN, United States, 47710